Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500105851Phase 4Not yet recruiting
Phase 4, randomised trial in obstructive sleep apnea hypopnea syndrome (OSAHS) comparing oliceridine arm with fentanyl arm (2 arms). Primary endpoint: success rate of analgesia. Planned start Jul 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500105851.